We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
A comprehensive guide to Herceptin (trastuzumab) dosage for HER2-positive breast, stomach, and esophageal cancers, tailored for readers in India. Learn about administration, typical dosages based on weight, and when to consult your doctor.
Facing a cancer diagnosis can feel overwhelming, and understanding your treatment plan is a vital step towards regaining control. For certain types of cancer, particularly HER2-positive breast cancer, and some stomach or esophageal cancers, a medication called Herceptin (trastuzumab) might be a key part of your therapy. This guide is designed to provide clear, practical information about Herceptin dosages, especially for our readers in India, helping you and your doctor make informed decisions. Remember, this information is for guidance only; your doctor's prescription is paramount.
Herceptin belongs to a class of drugs known as HER2/neu receptor antagonists. Its active ingredient, trastuzumab, is a targeted therapy. This means it works by specifically targeting cancer cells that have a protein called HER2 (human epidermal growth factor receptor 2) on their surface. Not all cancers have this protein. Your doctor will conduct tests on your tumor to determine if your cancer is HER2-positive before prescribing Herceptin. If it is, Herceptin can help slow or stop the growth of these specific cancer cells.
Herceptin is a prescription medication primarily used in adults to treat:
The crucial first step is a diagnostic test to confirm the HER2-positive status of your cancer. Without this confirmation, Herceptin is not an effective treatment.
Herceptin is not a pill you take at home. It is given as an intravenous (IV) infusion. This means it’s administered directly into your vein over a period of time, usually in a hospital or clinic setting. The medication comes as a powder in a vial, which a healthcare professional mixes with a liquid solution before infusion.
Determining the correct Herceptin dosage is a personalized process. It hinges on several factors, most importantly your body weight. Your doctor will calculate the precise dose for you. It’s essential to discuss your specific dosing schedule and amounts with your healthcare provider. Here’s a general overview of how dosages are typically determined:
When Herceptin is used for breast cancer, especially in its early stages or when combined with other treatments, the initial dose is often calculated based on your weight.
The total duration of Herceptin treatment for breast cancer can vary. In many cases, doctors recommend a treatment course lasting for 1 year. After this period, your doctor will evaluate your progress and may suggest continuing with a different treatment strategy.
For advanced cancers, such as metastatic breast cancer or HER2-positive stomach or esophageal cancer that has spread, the dosing regimen might differ slightly.
Treatment for these conditions often continues until the cancer shows signs of worsening or progression. Your oncologist will monitor your condition closely to determine the optimal duration of therapy.
Herceptin is available as a powder in single-dose vials. Each vial typically contains 150 milligrams (mg) of trastuzumab. This powder is reconstituted into a liquid solution by a healthcare professional for IV administration.
Your doctor is the ultimate authority on your Herceptin dosage. However, certain factors can lead to adjustments:
It is absolutely essential to maintain open communication with your healthcare team. You should consult your doctor immediately if you experience any of the following:
Access to advanced cancer therapies like Herceptin is available in India through various hospitals and cancer centers. The cost and availability can vary, and discussions with your oncologist and hospital administration regarding treatment expenses and potential support schemes are important. Many healthcare providers and patient advocacy groups in India can offer guidance and support throughout your treatment journey.
No, Herceptin is specifically for HER2-positive breast cancer. A diagnostic test is required to confirm this status before treatment begins.
No, Herceptin is administered via intravenous (IV) infusion and cannot be taken by mouth.
Treatment duration varies. For early breast cancer, it might be around 1 year. For metastatic cancers, treatment often continues as long as it is effective and the cancer is not progressing.
Common side effects can include fever, chills, nausea, vomiting, diarrhea, headache, and fatigue. More serious potential side effects involve heart problems and infusion reactions. Always discuss potential side effects with your doctor.
Yes, your doctor may adjust your dosage based on your weight changes, how you tolerate the medication, and its effectiveness.
Navigating cancer treatment is a journey, and knowledge is your ally. This guide provides a foundational understanding of Herceptin dosage. Always rely on your doctor for personalized medical advice and treatment plans tailored to your unique situation.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026